View all Webinars

Schwegman Lundberg & Woessner

Close     Close Mobile Menu

Categories

Recent

Lea Westman and Piers Blewett Share IP Strategies at MD&M Event
  When executives and inventors develop medical device technology, there...
Donate Professional Clothing at ChIPs Event to Help Women in Need
For women in need, obtaining professional interview clothing can present...
OutFront Gala Celebrates Progress Toward a Safe, Accepting Environment
Looking for a way to help support a safe, inclusive...
Gain Insights About EP Validation in Nov. 14 Webinar
EP validation has a three-stage process, from acceptance of text,...
Learn Tips for Analytics and Budgeting in Upcoming IPWatchdog Webinars
Process changes can help an organization use funds more wisely....
Join Us for November 7 MedTech Webinar
When medical device companies conduct fundraising or plan an exit...

Warren Woessner to Speak at Bio IP & Diagnostics Symposium

Warren Woessner, founding shareholder of Schwegman, will be speaking at the Bio IP & Diagnostics Symposium (Bio IPDx) on September 19, 2017, in Alexandria, VA.

Dr. Woessner will be speaking alongside Dr. Leslie Fischer of Novartis and Hans Sauer of Biotechnology Innovation Organization in a panel-style discussion titled “The Walls Are Closing In – The Bleak Future of Claims Reciting Natural ‘Correlations’ and Products of Nature.”  The three will discuss how recent developments regarding section 101 may once again increase patentability in this technology space.

Warren’s practice focuses on chemical patent law, including biotechnology, pharmaceuticals, vaccines, medical treatments, diagnostics, and biofuels and agricultural chemistry, including related opinion and licensing matters. In addition, he has served as an expert witness and also works in mediation of inventorship disputes and solutions for complex prosecution problems.

This seminar will be held at the Westin Alexandria from 7:30 am – 2:15 pm.

Register Here

 

  Back to All News